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J Thorac Cardiovasc Surg. 1999;117:939-51.Superior vena cava stenosis: A delayed BioGlue complication
George C. Economopoulos, MD,a George K. Dimitrakakis, MD,a E. Brountzos, MD,b and D. A. Kelekis, MD,bWe report a case of superior vena cava (SVC) ste-nosis with upper body venous hypertension afterapplication of biologic glue in the vicinity of theSVC after a double valve replacement and an
annuloplasty procedure. The SVC stenosis was managed success-
fully with balloon dilatation and stent placement.
Clinical Summary
A 63-year-old man was scheduled for double (aortic and mitral)
valve replacement and tricuspid valve annuloplasty. Bicaval can-
nulation was performed through the right atrial appendage for the
SVC and the atriocaval junction for the inferior vena cava; stan-
dard ascending aortic cannulation was also performed. Antegrade
and retrograde cold blood cardioplegia with moderate core hypo-
thermia (30°C) constituted the cardioprotective strategy. The ex-
posure of mitral and tricuspid valves was obtained through a
superior transseptal approach; exposure of the aortic valve was
obtained through a transverse aortotomy. After the mitral and the
aortic valve replacements, a DeVega tricuspid valve annuloplasty,
and closure of the atriotomy incision, there was persistent bleeding
from the dome of the left atrium. Despite adequate suturing, local
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doi:10.1016/j.jtcvs.2003.12.041sponge packing, reversal of all anticoagulants, and plasma and
platelet transfusions, the oozing persisted. A fair amount of Bio-
Glue (Cryolife, Inc, Kennesaw, Ga) was placed on the area, with
a successful result. The patient had an uneventful recovery, and he
was discharged on the ninth postoperative day.
The patient returned 8 months later, reporting headaches, diz-
ziness especially on bending, and significant swelling of the face
and neck. Echocardiography revealed a competent tricuspid valve
repair and two well-functioning artificial valves, with satisfactory
myocardial performance. A retroaortic and paracaval echodense
mass was noted to be compressing the SVC at its junction with the
right atrium (Figure 1). An upper-body venogram revealed a
severe stenosis (90%) of the SVC (Figure 2, A). Dilatation of the
SVC with 7-mm and 12-mm balloons, followed by placement of a
12  64-mm Wallstent (Boston Scientific, Watertown, Mass),
successfully relieved the stenosis (Figure 2, B). The patient is
doing well without recurrent stenosis 16 months after the proce-
dure.
Discussion
After the adverse effects of cyanoacrylate-based glue on the aortic
tissues became apparent,1-3 a new bovine albumin–based glue
cross-linked with glutaraldehyde, BioGlue, was introduced into the
cardiac surgical market as the new, nontoxic glue for hemostasis.
The product is a preparation of bovine albumin cross-linked with
glutaraldehyde to form a strong adhesive bond. It is supplied in a
two-barrel applicator; the two compartments contain albumin and
glutaraldehyde, which are mixed at the time of application. After
mixture, the glue solidifies in about 30 seconds and achieves
maximum strength in about 2 to 3 minutes.4 The use of BioGlue in
aortic surgery was met with great initial enthusiasm, because not
only did it increase the strength of the friable aortic walls in aortic
dissection when it was applied between the dissected aortic layers,
it was proved effective as a sealing agent at the anastomotic suture
5-8line.
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Brief CommunicationsRecently, experimental and clinical studies have reported on
local tissue damage, local inflammatory response, and risk of
pseudoaneurysm formation and great vessel stenosis when Bio-
Glue is applied circumferentially, especially in the pediatric pop-
ulation.9 In experiments with piglets, LeMaire and associates10
discovered that when BioGlue was applied circumferentially
around aortoaortic anastomoses, it impaired vascular growth and
caused anastomotic strictures. In our case we believe that an
inappropriately large amount of BioGlue was placed between the
roof of the left atrium, the adjacent superior cavoatrial junction,
and the aortic root. The initially liquid glue, helped by gravity,
encircled the cavoatrial junction. After it solidified, it caused the
stricture with time.
We believe that BioGlue should be applied sparingly, avoiding
spillage, because when the glue is still liquid it may gravitate to
dependent, not easily visible areas. Thus it may surround and
damage vascular or neuronal tissues, or even compress and con-
strict low-pressure vascular structures, when it solidifies.
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1500-6.New technologies for the treatment of type A aortic dissection: A case
report
Stefano Saccani, MD,a Francesco Nicolini, MD,a Bruno Borrello, MD,a Andrea Agostinelli, MD,a Pietro Larini, MD,b
Carla Marcato, MD,b and Tiziano Gherli, MD,a Parma, ItalyAortic arch replacement in the treatment of type Aaortic dissection is justified in emergency settings toprevent later complications,1 even if it is technicallydemanding and affected by mortality and morbidi-
ty.2,3 Evolution of residual false lumen remains unpredictable,
requiring further high-risk surgical procedures. We report a case of
type A aortic dissection treated with ascending aortic replacement
associated with a new stent graft positioned in the aortic arch and
completed with thoracic endovascular stent graft placement.
Clinical Summary
A 78-year-old woman was admitted for acute type A aortic dis-
section. Preoperative transesophageal echocardiography showed a
primary tear located above the aortic cusps and extending to the
descending thoracic aorta. Cardiopulmonary bypass was estab-
lished between the right subclavian artery and the right atrium. At
mild hypothermia, the ascending aorta was crossclamped, and cold
blood cardioplegia was administered through the coronary ostia.
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doi:10.1016/j.jtcvs.2004.01.020The proximal aortic stump was reconstructed with continuous
mattress sutures and Teflon collars after gelatin-resorcin-formol
glue application to the false channel. At a nasopharyngeal temper-
ature of 24°C, general circulation was arrested, and cerebral pro-
tection was obtained by means of right common carotid artery
perfusion at a rate of 10 mL · kg1 · min1 through the right
subclavian artery. Another tear was found near the origin of the
brachiocephalic trunk. The Djumbodis dissection system (Saint
Come-Chirurgie, Marseille, France), 9 cm long, was inserted in the
aortic arch and fixed to the aortic wall with 4 transfixed stitches.
The device consists of an uncovered stent made of Steel 316 L
provided in 3 lengths (4, 9, and 14 cm) and mounted on a
compliant balloon (Figure 1). The balloon is inflated to adapt the
stent to the shape of the aortic arch and to coapt aortic layers. The
deployed device presents a large-meshed web and can be super-
imposed at the origin of the epiaortic vessels without any danger of
obstruction. A 30° 5-mm endoscope positioned in the aortic arch
allowed us to control the correct deployment of the Djumbodis
system. The distal end of a Dacron graft was anastomosed to the
distal aortic stump and reconstructed with the same technique as
used with the proximal one. Extracorporeal circulation was re-
stored, and proximal anastomosis of the Dacron graft was per-
formed during rewarming of the patient. Selective antegrade ce-
rebral perfusion time was 28 minutes, and aortic arch inspection
requires 4 minutes of total circulatory arrest. Contrast-enhanced
computed tomographic (CT) scanning showed no patent false
lumen in the aortic arch. The patient was discharged in an asymp-
tomatic state 12 days after the operation. At 2 months’ follow-up
CT scanning, a dilation of the false lumen with an aortic isthmian
pseudoaneurysm was found: the patient underwent endovascular
thoracic stent graft insertion (2 segments, 32  32  230; Talent
World Medical Manufacturing Corp, Sunrise, Fla) through the left
femoral artery. Stent grafts were proximally positioned with partial
overlapping to the distal end of the Djumbodis dissection system
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